M. Tiniakou

High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen

Maria Liga, Evangelia Triantafyllou, M. Tiniakou et al. · Biology of Blood and Marrow Transplantation · 2012 · 80 citations · Full text

Immunohematology, Immunology, Transplantation Medicine +16

Immune function parameters at diagnosis in patients with myelodysplastic syndromes: Correlation with the FAB classification and prognosis

Argiris Symeonidis, A. Kourakli, Prokopis Katevas et al. · European Journal Of Haematology · 1991 · 45 citations

Comparison of allogeneic stem cell transplantation, high‐dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

Apostolia M. Tsimberidou, Niki Stavroyianni, Nora Viniou et al. · Cancer · 2003 · 42 citations

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia

Apostolia M. Tsimberidou, George Paterakis, George Androutsos et al. · Leukemia Research · 2002 · 37 citations

Hematological Malignancy, Health Sciences, Lung Resistance Protein +11

Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases

Carlo Zaninetti, Valeria Santini, M. Tiniakou et al. · Journal of Thrombosis and Haemostasis · 2017 · 35 citations · Full text

Hematological Malignancy, Myelodysplastic Syndrome, Bone Marrow Failure +7